A European industry group says EU efforts to ensure the quality of API made by manufactureres outside the region are inadequate and that mandatory inspections of overseas plants are a must.
Domestic regulatory efforts to improve ingredient quality will increase costs but Indian industry will remain competitive, according to the Secretary of Commerce.
Outsourcing-Pharma.com presents its weekly round-up of the latest movers and shakers in the world of pharmaceutical services. News from RPS, HCB Health and Cadient.
